The latest rise in COVID-19 statistics is bringing investors back to coronavirus stocks. That, combined with a top-down effort to develop an updated vaccine and get it in the arms of as many Americans as possible, juiced several stocks associated with fighting the disease.

(NASDAQ: NVAX) was among these titles, closing the day nearly 4% higher. That performance convincingly beat the 0.7% rise of the S 500 index on the day.

Late afternoon Friday, President Joe Biden said that he has formally requested that Congress provide additional funding for new COVID vaccines. He also tentatively recommended that all Americans receive updated jabs when they become available.

Continue reading

Source Fool.com